Are you an Innovator? Applications for Mass General Brigham Commercialization and Inclusive Leadership Program now open

MGB GRAPHICS CILP Program 220927 0912 150 POWERPOINT 2

The Mass General Brigham Commercialization and Inclusive Leadership Program (CILP) is a one-day in-person program on commercial application and inclusive leadership offered by the Mass General Brigham Innovator Community Expansion Initiative (ICEI) in collaboration with Babson College. This program supports the Innovator Community Expansion Initiative’s (ICEI) goal of increasing the pool of potential innovators across the Mass General Brigham system and providing tools and resources to drive excellence in commercial outcomes.

CILP will provide 50 participants the skills, resources and networks needed to grow not just as innovators but as leaders and proponents of commercialization at Mass General Brigham.

Who should apply?

  • Early career clinicians or researchers
  • Individuals who
    • have not executed a license at Mass General Brigham
    • are motivated to start their commercialization journey
    • want to be a part of our innovator community

The one-day in-person program is scheduled for March 14, 2023, from 9 – 5PM at the Babson Executive Conference Center. We aim to deliver this program in-person but will monitor the COVID situation closely.

Applications are due January 15, 2023. Click here to apply

Contact icei@partners.org with any questions.

Most Recent Posts:

At Globe Summit, Mass General Brigham panelists explore the impact of AI

Exploring AI’s Impact on Industry, left to right: panelists, Marc Succi, MD, Daniela Rus and Paul English,…

Read More

Perspectives on WMIF 2023 from Garibyan

Lilit Garibyan, MD, PhD, a dermatologist at the Wellman Center for Photomedicine and an associate professor of…

Read More
Blog Fortune IRA responses image

The Inflation Reduction Act: Responses From Experts on Implications for Biopharmaceutical Innovation

September 21, 2023—Two panel discussions on the Inflation Reduction Act at the World Medical Innovation Forum in…

Read More